↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Nahi H) ;pers:(Alici E)"

Search: WFRF:(Nahi H) > Alici E

Result 1-10 of 44

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	Falk, IJ, et al. (author) The impact of ABCB1 single nucleotide polymorphisms on the outcome in lenalidomide treated multiple myeloma patients 2017 In: CANCER RESEARCH. - 0008-5472. ; 77 Conference paper (other academic/artistic)
2.	Halvarsson, B, et al. (author) Direct evidence for a polygenic etiology in familial multiple myeloma 2018 In: EUROPEAN JOURNAL OF HUMAN GENETICS. - 1018-4813. ; 26, s. 558-558 Conference paper (other academic/artistic)
3.	Afram, G, et al. (author) Conditioning with melphalan 200 mg/m2 and subsequent ASCT improves progression-free and overall survival in elderly myeloma patients compared to standard of care 2022 In: European journal of haematology. - : Wiley. - 1600-0609 .- 0902-4441. ; 109:6, s. 749-754 Journal article (peer-reviewed)
4.	Afram, G, et al. (author) Impact of performance status on overall survival in patients with relapsed and/or refractory multiple myeloma: Real-life outcomes of daratumumab treatment 2020 In: European journal of haematology. - : Wiley. - 1600-0609 .- 0902-4441. ; 105:2, s. 196-202 Journal article (peer-reviewed)
5.	Afram, G, et al. (author) Improved survival in multiple Myeloma patients undergoing autologous stem cell transplantation is entirely in the standard cytogenetic risk groups 2021 In: European journal of haematology. - : Wiley. - 1600-0609 .- 0902-4441. ; 106:4, s. 546-554 Journal article (peer-reviewed)
6.	Alici, E, et al. (author) Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components 2008 In: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 111:6, s. 3155-3162 Journal article (peer-reviewed)abstract Multiple myeloma (MM) is an incurable plasma cell malignancy with poor outcome. The most promising therapeutic options currently available are combinations of transplantation, targeted pharmacotherapy, and immunotherapy. Cell-based immunotherapy after hematopoietic stem-cell transplantation has been attempted, but with limited efficacy. Natural killer (NK) cells are interesting candidates for new means of immunotherapy; however, their potential clinical use in MM has not been extensively studied. Here, we explored the possibility of expanding NK cells from the peripheral blood of 7 newly diagnosed, untreated MM patients, using good manufacturing practice (GMP)–compliant components. After 20 days of culture, the number of NK cells from these patients had expanded on average 1600-fold. Moreover, expanded NK cells showed significant cytotoxicity against primary autologous MM cells, yet retained their tolerance against nonmalignant cells. Based on these findings, we propose that autologous NK cells expanded ex vivo deserve further attention as a possible new treatment modality for MM.
7.	Alici, E, et al. (author) Ex vivo expanded autologous natural killer cells as a novel therapeutic approach in multiple myeloma 2008 In: HUMAN GENE THERAPY. - 1043-0342. ; 19:10, s. 1183-1183 Conference paper (other academic/artistic)
8.	Alici, E, et al. (author) Re-challenging with anti-CD38 monotherapy in triple-refractory multiple myeloma patients is a feasible and safe approach 2016 In: British journal of haematology. - : Wiley. - 1365-2141 .- 0007-1048. ; 174:3, s. 473-477 Journal article (other academic/artistic)
9.	Andreasson, A., et al. (author) Bortezomib, response and retreatment in 1st, 2nd, 3rd and 4th line of treatment in patients with multiple myeloma 2012 In: Haematologica. - : Ferrata Storti Foundation. - 0390-6078 .- 1592-8721. ; 97, s. 610-610 Journal article (other academic/artistic)
10.	Caliskan, C, et al. (author) Reinstating anti-tumor activity of Natural Killer cells 2019 In: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA. - : Elsevier BV. - 2152-2650. ; 19:10, s. E158-E158 Conference paper (other academic/artistic)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 44

Refine your search

Type of publication: journal article (30); conference paper (14)

Type of content: other academic/artistic (22); peer-reviewed (22)

Author/Editor: Alici, E (44)Undo refine; Nahi, H (44); Lund, J. (23); Gahrton, G (22); Uttervall, K (15); Wagner, AK (11); show more...; Kashif, M (10); Gran, C (10); Ljunggren, HG (9); Chrobok, M (9); Afram, G (8); Liwing, J (7); Luong, V (6); Bruchfeld, JB (5); Hussain, A (4); Jansson, M. (4); Lundqvist, A (4); Susek, KH (4); Aschan, J (4); GRUBER, A (4); Chaireti, R (3); Dilber, MS (3); Quezada, HC (3); Hansson, M (2); Ljungman, P (2); Holmberg, E. (2); Gustafsson, C (2); Mellqvist, UH (2); Waage, A (2); Turesson, I (1); Paul, E. (1); Ali, M (1); Samuelsson, J (1); Wagner, A. (1); Sarhan, D (1); Holmberg, Erik, 1951 (1); Wersall, JD (1); Bjorkstrand, B (1); Hemminki, K (1); Nilsson, B (1); Deneberg, S (1); Langer, C. (1); Lotfi, K (1); Andreasson, A (1); Goldschmidt, H (1); Weinhold, N (1); Wihlborg, A (1); Niroula, A (1); Johnsson, E (1); Mellqvist, U (1); show less...

University: Karolinska Institutet (44); University of Gothenburg (1); Royal Institute of Technology (1)

Language: English (44)

Research subject (UKÄ/SCB): Medical and Health Sciences (2)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view